Determination of diminazene aceturate in pharmaceutical formulations by HPLC and identification of related substances by lC/MS

Tools

Atsriku, C. and Watson, D.G. and Tettey, J.N.A. and Grant, M.H. and Skellern, G.G. (2002) Determination of diminazene aceturate in pharmaceutical formulations by HPLC and identification of related substances by lC/MS. Journal of Pharmaceutical and Biomedical Analysis, 30 (4). pp. 979-986. ISSN 1873-264X (https://doi.org/10.1016/S0731-7085(02)00450-8)

Full text not available in this repository.Request a copy

Abstract

A validated, reversed-phase, isocratic high-performance liquid chromatographic method for the simultaneous assay of diminazene aceturate, antipyrine (excipient) and diminazene impurities in pharmaceutical formulations is described. The chromatographic system consisted of a Lichrospher-60 RP-select B column with a mobile phase composition of acetonitrile–methanol–ammonium formate (pH 4.0, 20 mM) (10:10: 80 v/v/v) and UV detection at 254 nm. The method is specific, precise and accurate for the determination of diminazene in the presence of its manufacturing and degradation impurities with a limit of detection and quantification of 50 ng/ml and 10 μg/ml (RSD<3.0%), respectively. The major manufacturing impurity [1-(4 amidino phenyl)3-(4 carbamoyl phenyl)-triazene] and a degradant (p-aminobenzamidine) of diminazene aceturate have been resolved and identified by liquid chromatography/electrospray ionization-mass spectrometry operated in a positive ion mode.

ORCID iDs

Atsriku, C., Watson, D.G. ORCID logoORCID: https://orcid.org/0000-0003-1094-7604, Tettey, J.N.A., Grant, M.H. ORCID logoORCID: https://orcid.org/0000-0002-7712-404X and Skellern, G.G.;
CORE (COnnecting REpositories)